Judge Says Actavis Must Continue to Sell Namenda, a Drug for Alzheimer’s Disease
Thursday, December 11, 2014 - 22:50
in Health & Medicine
New York’s attorney general had accusing Actavis of forcing patients to switch to a newer version of the drug to thwart competition from generic manufacturers.